Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by StockNews.com

by · The Markets Daily

Equities research analysts at StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a report issued on Saturday. The firm set a “sell” rating on the stock.

Ampio Pharmaceuticals Price Performance

Shares of AMPE opened at $0.00 on Friday. Ampio Pharmaceuticals has a 12-month low of $0.00 and a 12-month high of $7.47. The stock has a market cap of $2,497.00, a PE ratio of 0.00 and a beta of 3.49.

Ampio Pharmaceuticals Company Profile

(Get Free Report)

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.

Read More